Combined TNF Inhibitor and Growth Factor Serum from Japan
Bulk mixed preparation of tumor necrosis factor (TNF) inhibitors like infliximab with growth factors (GF) for autoimmune disease modulation. HTS 3002.14.00 applies to such mixed immunological products (TNF, GF) obtained biotechnologically, excluding retail forms.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include biotech origin certificates showing modification processes for TNF/GF regulation
• Avoid measured dose packaging; bulk drums qualify for 3002.14 over retail headings